AndreasGMoraitisMD
Endocrinology • Sunny Isles Beach, FLAdrenal Disease, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology
Assistant Professor, Internal Medicine, University of Michigan Medical School
Dr. Moraitis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
18101 Collins Ave
Lobby C Suite 1300
Sunny Isles Beach, FL 33160Phone+1 734-998-2450Fax+1 734-647-2145- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2010 - 2012
New York Downtown HospitalResidency, Internal Medicine, 2007 - 2010
University of AthensClass of 2002
Certifications & Licensure
FL State Medical License 2015 - 2025
MI State Medical License 2012 - 2025
VA State Medical License 2011 - 2024
MD State Medical License 2010 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Study to Evaluate CORT125134 in Participants With Cushing's Syndrome Start of enrollment: 2016 Jun 01
- Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery Start of enrollment: 2016 Nov 01
- Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome Start of enrollment: 2018 May 07
- Join now to see all
Publications & Presentations
PubMed
- Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Card...Diane M Donegan, Rosario Pivonello, Antonio Stigliano, Pina Lardo, Tara Kearney, Emese Mezősi, Ezio Ghigo, Roberta Giordano, Cary N Mariash, Richard A Feelders, Kirste...> ;Endocrine Practice. 2024 Jan 1
- 4 citationsGenetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators.Saptarshi Mallick, Jayati Chakrabarti, Jennifer Eschbacher, Andreas G Moraitis, Andrew E Greenstein, Jared Churko, Kelvin W Pond, Antonia Livolsi, Curtis A Thorne, And...> ;Translational Research. 2023 Jun 1
- Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, ...Rosario Pivonello, Irina Bancos, Richard A Feelders, Atil Y Kargi, Janice M Kerr, Murray B Gordon, Cary N Mariash, Massimo Terzolo, Noel Ellison, Andreas G Moraitis> ;Frontiers in Endocrinology. 2022 Jan 1
- Join now to see all
Journal Articles
- Clinical and hormonal responses to mifepristone therapy in two patients with ACTH independent Cushing's syndromeAndreas G.Moraitis MD and Richard Auchus, AACE case reports, 7/19/2015
Press Mentions
Improvements in Excess Cortisol Activity with RelacorilantApril 29th, 2019
Professional Memberships
- Member
- Member
- Member
Other Languages
- Greek
Hospital Affiliations
University of Michigan Medical CenterAnn Arbor, Michigan
Industry Relationships
- Medical Director, Corcept Therapeutics2014 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
